Health at a Glance 2015
OECD Indicators
This new edition of Health at a Glance presents the most recent comparable data on the performance of health systems in OECD countries. Where possible, it also reports data for partner countries (Brazil, China, Colombia, Costa Rica, India, Indonesia, Latvia, Lithuania, Russian Federation and South Africa). Compared with the previous edition, this new edition includes a new set of dashboards of health indicators to summarise in a clear and user-friendly way the relative strengths and weaknesses of OECD countries on different key indicators of health and health system performance, and also a special focus on the pharmaceutical sector. This edition also contains new indicators on health workforce migration and on the quality of health care.
- Click to access:
-
Click to download PDF - 4.41MBPDF
-
Click to download EPUB - 16.52MBePUB
Share of generic market
All OECD countries see the development of generic markets as a good opportunity to increase efficiency in pharmaceutical spending but many do not fully exploit the potential of generics (). In 2013, generics accounted for more than three-quarters of the volume of pharmaceuticals sold in the United States, the United Kingdom, Chile, Germany and New Zealand, while they represented less than one-quarter of the market in Luxembourg, Switzerland, Italy, and Greece.
Also available in: French
- Click to access:
-
Click to download PDF - 262.24KBPDF